Hirtle Callaghan & Co’s Praxair Inc PX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-8,993
Closed -$1.17M 432
2014
Q4
$1.17M Sell
8,993
-420
-4% -$53.2K 0.27% 59
2014
Q3
$1.21M Sell
9,413
-895
-9% -$117K 0.2% 58
2014
Q2
$1.37M Buy
10,308
+693
+7% +$90.8K 0.19% 74
2014
Q1
$1.26M Sell
9,615
-137
-1% -$17.8K 0.21% 65
2013
Q4
$1.27M Sell
9,752
-130
-1% -$16.2K 0.17% 66
2013
Q3
$1.19M Buy
9,882
+9,382
+1,876% +$1.11M 0.19% 66
2013
Q2
$58K Buy
+500
New +$56.9K 0.67% 29

Other funds holding PX

Hirtle Callaghan & Co's PX Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of Praxair Inc (PX) in Q1 2015, closing a stake of 8,993 shares — an estimated $1.17M sold.

Hirtle Callaghan & Co first reported a position in PX in Q2 2013 and held it in 7 quarters. The position peaked at $1.37M in Q2 2014. 891 funds tracked by Wall St. Rank hold PX as of Q1 2015.

  • Hirtle Callaghan & Co reported no remaining Praxair Inc position as of Q1 2015 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 8,993 Praxair Inc shares in Q1 2015, an estimated $1.17M.
  • Hirtle Callaghan & Co first reported a position in Praxair Inc in Q2 2013 and held it in 7 quarters.
  • Hirtle Callaghan & Co's Praxair Inc position peaked at $1.37M in Q2 2014.
  • 891 funds tracked by Wall St. Rank held Praxair Inc as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.